The Invus Group Overview
- Investor Type
-
PE/Buyout
- Status
-
Active
- Professionals
-
48
- Investments
-
284
- Portfolio
-
98
- Exits
-
109
The Invus Group General Information
Company Description
Founded in 1985, The Invus Group is a private equity firm based in New York, New York. The firm invests across a wide range of industries including consumer products and services, food, specialty retail, software, biotech, medical devices and products, and professional services.
Business Details
Website
www.invus.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 750 Lexington Avenue
- 30th Floor
- New York, NY 10022
- United States
The Invus Group Investments (284)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Cartesian Therapeutics | 08-Aug-2024 | 0000 | 00000 | Drug Discovery | Generating Revenue/Not Profitable | |
| Knime | 06-Aug-2024 | 00 000000000 | 000.00 | Business/Productivity Software | Generating Revenue | 00000000 000 |
| Autobahn Therapeutics | 24-Jul-2024 | 00000 00000 | 00000 | Biotechnology | Clinical Trials - Phase 1 | |
| Scorpion Therapeutics | 16-Jul-2024 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
| Cardurion | 10-Jul-2024 | Later Stage VC | 00000 | Biotechnology | Pre-Clinical Trials |
The Invus Group Exits (109)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Splash | 04-Sep-2024 | 0000000000 | |
| Cerevel Therapeutics | 01-Aug-2024 | 000000000000 | 00.00 |
| Recursion Pharmaceuticals | 26-Jun-2024 | 000000 00000 | 00000 |
| Harpoon Therapeutics | 11-Mar-2024 | 000000000000 | 00000 |
| PepGen | 07-Feb-2024 | Public Investment 2nd Offering | 000.00 |
The Invus Group Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
The Invus Group Management, Team & Partners (70)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Raymond Debbane | Founder, President & Chief Executive Officer | 00 | 0 | New York, NY | |
| Philip Bafundo | Chief Financial Officer | New York, NY | |||
| Michelle Garzon | Chief Operating Officer of Public Equities, United States | New York, NY | |||
| Jonathan Luick JD | Chief Operating Officer, Public Equity, United States | New York, NY | |||
| Evren Bilimer | Managing Director, Private Equity | 0 | 0 | New York, NY |
The Invus Group FAQs
-
What is The Invus Group?
Founded in 1985, The Invus Group is a private equity firm based in New York, New York.
-
When was The Invus Group founded?
The Invus Group was founded in 1985.
-
Who is the founder of The Invus Group?
Raymond Debbane is the founder of The Invus Group.
-
Who is the CEO of The Invus Group?
Raymond Debbane is the CEO of The Invus Group.
-
Where is The Invus Group headquartered?
The Invus Group is headquartered in New York, NY.
-
What is The Invus Group's total asset value?
The Invus Group has around 0000 in total assets under management.
-
How many investments has The Invus Group made?
The Invus Group has made 284 investments.
-
What has The Invus Group invested in?
The Invus Group has made numerous investments in companies like Cartesian Therapeutics, Knime, and Autobahn Therapeutics within the Drug Discovery, Business/Productivity Software, and Biotechnology industries.
-
What has The Invus Group invested in recently?
The Invus Group's latest investment was on 08-Aug-2024 in Cartesian Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
